PHARMACY HEALTH IBUPROFEN SODIUM 256mg (as sodium dihydrate) film coated tablet blister pack (new formulation)

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

ibuprofen sodium dihydrate, Quantity: 256 mg

Available from:

Neo Health (OTC) Pty Ltd

Pharmaceutical form:

Tablet, film coated

Composition:

Excipient Ingredients: xylitol; microcrystalline cellulose; magnesium stearate; croscarmellose sodium; colloidal anhydrous silica; titanium dioxide; hypromellose; macrogol 400

Administration route:

Oral

Units in package:

24, 20, 8, 40, 4 (Samples), 2, 4, 96, 80, 6 (Sample), 10, 12, 72, 48

Prescription type:

Not scheduled. Not considered by committee, (S2) Pharmacy Medicine

Therapeutic indications:

Temporary relief of pain (and discomfort) associated with headache, migraine headache, tension headache, sinus pain, toothache, dental procedures,,backache, muscular aches and pains, period pain, sore throat, arthritis, rheumatic pain where inflammation is present, and the aches and pains,associated with colds and flu. Reduces fever.

Product summary:

Visual Identification: White to off white, round, biconvex film-coated tablets.; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Registered

Authorization date:

2023-04-27